Last reviewed · How we verify

NCT06852118

Using the Adductor Magnus Plain Block as an Innovative Approach for Sciatic Nerve Block for Lower Limb Surgeries.

Active, enrolled NA Last updated 28 February 2025
What this trial tests

NA trial testing AMM Group: Adductor Magnus Muscle Plane approach + Femoral Nerve Blocks in Adductor Magnus Plain Injection for Sciatic Nerve Block in 60 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 October 2024
Primary endpoint
30 June 2025
30 June 2025

Quick facts

Lead sponsorMohammed Gaber Saad
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date1 October 2024
Primary completion30 June 2025
Estimated completion30 June 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Mohammed Gaber Saad

Who can join

Adults 18 to 75, any sex, with Adductor Magnus Plain Injection for Sciatic Nerve Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the goal of this clinical trial is to compare the efficacy of adductor magnus muscle plane injection as an approach for sciatic nerve block to sub-gluteal approach in combination with femoral nerve blocks as perioperative analgesia in knee surgeries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Mohammed Gaber Saad trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06852118.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing